These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 21952995)
41. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149 [TBL] [Abstract][Full Text] [Related]
42. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Gritz DC; Wong IG Ophthalmology; 2004 Mar; 111(3):491-500; discussion 500. PubMed ID: 15019324 [TBL] [Abstract][Full Text] [Related]
43. Serum hyaluronic acid in polymyositis: high serum levels tend to correlate with disease activity. Silva MB; Silva MG; Shinjo SK Acta Reumatol Port; 2014; 39(3):248-53. PubMed ID: 25326405 [TBL] [Abstract][Full Text] [Related]
44. [Comparison of clinical characteristics of patients with riboflavin responsive lipid storage myopathy versus polymyositis]. Wang Y; Liu X; Wang Z; Zhang W; Lü H; Hu W; Yuan Y Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(7):503-6. PubMed ID: 24767291 [TBL] [Abstract][Full Text] [Related]
45. Adult dermatomyositis: experience of a Brazilian tertiary care center. Souza FH; Barros TB; Levy-Neto M; Shinjo SK Rev Bras Reumatol; 2012 Dec; 52(6):897-902. PubMed ID: 23223700 [TBL] [Abstract][Full Text] [Related]
46. Overall Clinical Features of Type 2 Diabetes Mellitus With Respect to Gender. Ali J; Haider SMS; Ali SM; Haider T; Anwar A; Hashmi AA Cureus; 2023 Mar; 15(3):e35771. PubMed ID: 37020489 [TBL] [Abstract][Full Text] [Related]
47. Predictive model of diabetes mellitus in patients with idiopathic inflammatory myopathies. Nie Q; Qin L; Yan W; Luo Q; Ying T; Wang H; Wu J Front Endocrinol (Lausanne); 2023; 14():1118620. PubMed ID: 37139334 [TBL] [Abstract][Full Text] [Related]
48. Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies. Qin L; Zhang Y; Yang X; Wang H J Clin Hypertens (Greenwich); 2021 Aug; 23(8):1556-1566. PubMed ID: 33973700 [TBL] [Abstract][Full Text] [Related]
49. Polymyositis/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease. Syue SH; Chang YH; Shih PJ; Lin CL; Yeh JJ; Kao CH Ann Transl Med; 2020 Mar; 8(5):202. PubMed ID: 32309349 [TBL] [Abstract][Full Text] [Related]
50. Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases. Mavrogeni SI; Markousis-Mavrogenis G; Koutsogeorgopoulou L; Dimitroulas T; Vartela V; Rigopoulos A; Noutsias M; Kolovou G Heart Fail Rev; 2019 Jul; 24(4):489-498. PubMed ID: 30830518 [TBL] [Abstract][Full Text] [Related]
51. Quality of life correlates with muscle strength in patients with dermato- or polymyositis. Poulsen KB; Alexanderson H; Dalgård C; Jacobsen S; Weile L; Diederichsen LP Clin Rheumatol; 2017 Oct; 36(10):2289-2295. PubMed ID: 28585061 [TBL] [Abstract][Full Text] [Related]
52. Inflammatory myopathies: One-center experience. Işık M; Bilgen Ş; Doğan İ; Kılıç L Eur J Rheumatol; 2014 Sep; 1(3):96-100. PubMed ID: 27708887 [TBL] [Abstract][Full Text] [Related]
53. The olfactory function is impaired in patients with idiopathic inflammatory myopathies. Iaccarino L; Shoenfeld N; Rampudda M; Zen M; Gatto M; Ghirardello A; Bassi N; Punzi L; Shoenfeld Y; Doria A Immunol Res; 2014 Dec; 60(2-3):247-52. PubMed ID: 25391613 [TBL] [Abstract][Full Text] [Related]
54. Pulmonary involvement in polymyositis and in dermatomyositis. Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766 [TBL] [Abstract][Full Text] [Related]
55. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047 [TBL] [Abstract][Full Text] [Related]
56. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162 [TBL] [Abstract][Full Text] [Related]
57. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Chahin N; Engel AG Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720 [TBL] [Abstract][Full Text] [Related]
58. The high prevalence of metabolic syndrome in polymyositis. de Souza FH; Shinjo SK Clin Exp Rheumatol; 2014; 32(1):82-7. PubMed ID: 24144101 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender. Souza FH; Levy-Neto M; Shinjo SK Rev Bras Reumatol; 2011; 51(5):428-83. PubMed ID: 21952995 [TBL] [Abstract][Full Text] [Related]